TREA

88807844 - RED CELL THERAPEUTICS

Follow

Information

  • Trademark
  • 88807844
  • Serial Number
    88807844
  • Registration Number
    6532454
  • Filing Date
    February 24, 2020
    4 years ago
  • Registration Date
    October 19, 2021
    3 years ago
  • Transaction Date
    October 19, 2021
    3 years ago
  • Status Date
    October 19, 2021
    3 years ago
  • Location Date
    October 19, 2021
    3 years ago
  • First Use Anywhere Date
    November 11, 2020
    4 years ago
  • First Use In Commerce Date
    November 11, 2020
    4 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    FALK, JONATHAN ROBERT
  • Attorney Docket Number
    R07652000501
    Attorney Name
    Christina M. Licursi
    Law Office Assigned Location Code
    M20
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
RED CELL THERAPEUTICS
Case File Statements
  • D10000: "CELL THERAPEUTICS"
  • GS0051: Cells for medical or clinical use for the treatment of a variety of human diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders, neurological diseases and disorders, hematological diseases and disorders, dermatological diseases and disorders, ophthalmological diseases and disorders, gastrointestinal diseases and disorders, genitourinary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, connective tissues diseases and disorders, and enzyme deficiency diseases and disorders; pharmaceutical preparations of engineered erythroid cells for medical or clinical use for the treatment of a variety of human diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders, neurological diseases and disorders, hematological diseases and disorders, dermatological diseases and disorders, ophthalmological diseases and disorders, gastrointestinal diseases and disorders, genitourinary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, connective tissues diseases and disorders, and enzyme deficiency diseases and disorders; engineered erythroid cells for medical or clinical use for the treatment of a variety of human diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders, neurological diseases and disorders, hematological diseases and disorders, dermatological diseases and disorders, ophthalmological diseases and disorders, gastrointestinal diseases and disorders, genitourinary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, connective tissues diseases and disorders, and enzyme deficiency diseases and disorders; none of the foregoing used as vitamin-mineral supplements or for animals
Case File Event Statements
  • 10/19/2021 - 3 years ago
    30 - REGISTERED-SUPPLEMENTAL REGISTER Type: R.SR
  • 9/15/2021 - 3 years ago
    29 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 9/7/2021 - 3 years ago
    28 - APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER Type: CNTA
  • 9/7/2021 - 3 years ago
    27 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 9/7/2021 - 3 years ago
    26 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 9/7/2021 - 3 years ago
    25 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 9/7/2021 - 3 years ago
    24 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 7/21/2021 - 3 years ago
    23 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/20/2021 - 3 years ago
    22 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/20/2021 - 3 years ago
    21 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 2/9/2021 - 3 years ago
    20 - NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED Type: AAUA
  • 2/6/2021 - 3 years ago
    19 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 2/6/2021 - 3 years ago
    18 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 2/6/2021 - 3 years ago
    17 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 2/6/2021 - 3 years ago
    16 - USE AMENDMENT ACCEPTED Type: IUAA
  • 1/12/2021 - 3 years ago
    15 - AMENDMENT TO USE PROCESSING COMPLETE Type: AUPC
  • 11/19/2020 - 4 years ago
    14 - USE AMENDMENT FILED Type: IUAF
  • 11/20/2020 - 4 years ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 11/19/2020 - 4 years ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 11/19/2020 - 4 years ago
    11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 11/19/2020 - 4 years ago
    10 - TEAS AMENDMENT OF USE RECEIVED Type: EAAU
  • 5/20/2020 - 4 years ago
    9 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 5/20/2020 - 4 years ago
    8 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 5/20/2020 - 4 years ago
    7 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 5/13/2020 - 4 years ago
    6 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/21/2020 - 4 years ago
    5 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Type: AMPX
  • 3/13/2020 - 4 years ago
    4 - ASSIGNED TO LIE Type: ALIE
  • 3/6/2020 - 4 years ago
    3 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI
  • 2/27/2020 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 2/27/2020 - 4 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP